Lung cancer pathophysiology ppt powerpoint presentation pictures visual aids

So the main culprits you'll hear about are EGFR, KRAS, ALK, and p53 mutations. EGFR and ALK basically hijack your cell's growth signals - cells just keep dividing like crazy. KRAS is honestly the worst because it screws up tons of different pathways at once. Then there's p53, which is supposed to be like your genome's security guard, but when it's mutated you lose DNA repair and the ability to kill off bad cells. The good news? EGFR and ALK have decent targeted drugs now. KRAS was impossible to treat until like last year. But seriously, push for molecular testing - it completely changes what treatments will actually work for you.

So basically, stuff like cigarettes, asbestos, and radon mess up your lung cells' DNA - they hit the important genes like p53 and KRAS that normally keep cancer in check. What makes it worse is all that damage causes inflammation, which creates these nasty oxygen molecules that trash your DNA even more. It's like a snowball effect, honestly. Your cells try to repair themselves but eventually they can't keep up. Takes years though - we're talking decades of damage piling up. That's why when you're looking at cases, the smoking history is usually a dead giveaway for what went wrong at the molecular level.

Think of inflammation as cancer's best friend - which is pretty messed up when you think about it. Chronic stuff like COPD keeps your lungs in this endless damage-repair cycle. Your inflammatory cells start pumping out cytokines and growth factors that actually help tumors grow and form blood vessels. The oxidative stress also trashes your DNA and screws with tumor suppressor genes. So basically your body's trying to heal itself but ends up creating the perfect environment for cancer cells. That's why catching and treating chronic lung inflammation early matters so much for people at risk.

So the subtype totally changes everything about treatment. NSCLC grows slower, stays put longer - that's when you can do surgery or those targeted therapies if they've got EGFR mutations and stuff. SCLC though? That one's a nightmare. Spreads everywhere before you even catch it, so surgery's usually pointless by then. You're stuck doing chemo and radiation right away. At least it responds well at first, I guess that's something. But yeah, get that tissue typing done fast because it literally determines if you're cutting, targeting specific mutations, or just hitting it hard with systemic treatment.

So basically, lung cancer spreads when cells break off from the main tumor and get into your bloodstream or lymph nodes. They travel around and set up shop in other organs - super common spots are brain, bones, liver, and adrenal glands. The lungs have tons of blood vessels which honestly makes this whole process way too easy for the cancer. Different mutations like EGFR actually change where it's likely to spread, which is kinda fascinating from a science perspective. That's why docs always scan those typical sites when they're staging patients.

So basically the tumor builds this crazy protective shield around itself. All these support cells - like fibroblasts and immune cells - start helping the cancer instead of fighting it. Low oxygen levels make everything worse, triggering pathways that boost invasion and drug resistance. The whole surrounding tissue gets remodeled too, which blocks chemo from getting through properly. It's wild how the tumor literally recruits its own backup crew through chemical signals. That's why docs can't just target cancer cells anymore - you've gotta hit the entire support system or it'll just keep protecting itself.

So lung tumors literally can't grow past 2-3mm without new blood vessels - they just starve otherwise. VEGF drives this whole process, which is why we target it therapeutically. Bevacizumab is the main anti-VEGF drug, though tbh the survival gains aren't amazing. There's also multi-targeted TKIs like sunitinib that hit VEGF receptors plus other stuff. Oh, and anti-angiogenic drugs work way better with chemo than alone - apparently it "normalizes" the tumor blood vessels so chemo gets delivered better. Makes sense I guess.

So basically, lung cancer cells are sneaky as hell - they've figured out how to shut down your immune system before it can fight back. They pump out chemicals that suppress immune responses and recruit these regulatory T-cells that protect the tumor. Plus they have these checkpoint proteins (like PD-L1) that literally signal your T-cells to leave them alone. It's wild how good they are at this. That's why treatment is so tough - you're not just killing cancer, you're trying to wake up an immune system that's been completely hijacked. Thank god for those newer immunotherapy drugs though, they're actually helping people's bodies fight back again.

Cancer cells are sneaky - they completely change how they use energy to grow faster. Instead of normal respiration, they switch to glycolysis even with plenty of oxygen around (that's the Warburg effect). They also go crazy for glutamine and pump out more fatty acids. Honestly, it's kind of impressive how they hack these systems. The whole glucose thing is why PET scans light up tumors so well - they're just glucose hogs. Oh, and there's some cool stuff happening with drugs that target this metabolic weirdness. Metformin's being tested, plus some glutaminase inhibitors that look promising.

So epigenetic changes mess with lung cancer cells without actually altering the DNA sequence itself - we're talking DNA methylation, histone modifications, microRNAs all going nuts. Tumor suppressor genes get silenced when they should be doing their job, oncogenes get way overactive. Here's what's wild though: this creates totally different molecular subtypes that respond completely differently to treatment. Patients with hypermethylated tumors often do way better on certain targeted therapies or immunotherapies. Bottom line - you've gotta check both the epigenetic profile AND genetic mutations when planning treatment. Honestly, the epigenetic stuff is becoming just as crucial for figuring out what'll work.

So there's circulating tumor DNA (ctDNA) - that's probably your best shot since it catches genetic mutations super early, way before symptoms hit. Traditional markers like CEA and CYFRA 21-1 are still used too. The research side gets pretty crazy though - they're looking at microRNAs, autoantibodies, even analyzing what you breathe out for volatile compounds. Wild stuff, right? Liquid biopsies with ctDNA beat tissue sampling since they're way less invasive. Plus tracking ctDNA levels during treatment gives real-time feedback on whether the therapy's actually working or not.

So basically, smoker lung cancers are caused by all that direct DNA damage from cigarette toxins - you get tons of mutations hitting KRAS, p53, the usual suspects. Non-smokers are different though. Their cancers usually come from things like EGFR mutations or ALK rearrangements instead. What's actually cool is that non-smoker cancers respond way better to targeted drugs. I'd honestly push hard for full molecular testing right away if your patient doesn't smoke. They're much more likely to have something you can actually target with precision therapy, which makes a huge difference in outcomes.

Yeah, comorbidities are brutal for lung cancer patients. COPD, diabetes, heart problems - they all create this inflammatory mess that basically feeds the tumor. Treatment becomes this impossible juggling act too. You can't be as aggressive with chemo or radiation because their bodies just can't handle it. Lower doses mean worse outcomes, obviously. What really gets me is how fast these patients decline compared to healthier ones. The disease just steamrolls them. Best thing you can do is hit those comorbidities hard from day one. Don't just focus on the cancer - treat everything.

So cancer stem cells are basically the worst part of lung cancer - they're like the master cells that can turn into any other cancer cell type. What makes them super dangerous? They resist chemo and radiation way better than regular cancer cells because they've got these pumps that literally kick drugs out. Plus they're really good at repairing their own DNA damage, which is honestly pretty unfair. They're also the main drivers behind metastasis, helping cancer spread to new spots. It's like trying to kill a weed but only getting the leaves - the root keeps growing back. That's why doctors are looking at combo treatments now.

Dude, PET-CT with these new tracers is honestly pretty wild - it's like watching cancer biology happen live. Beyond just glucose, they're targeting hypoxia markers and proliferation rates now. The hypoxia stuff is fascinating because you can literally see which tumor parts are starved for oxygen (those are usually the nasty aggressive ones). Diffusion-weighted MRI is also revealing crazy detail about tumor environments we never saw before. What's nuts is these aren't just for diagnosis anymore - they're showing us how tumors actually adapt over time. Check out recent FMISO and FLT tracer studies if you're curious.